Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension - Trenkwalder, C; Benes, H; Grote, L (Lancet Neurol, 2013)
et al.